The MAP kinase-interacting kinases regulate cell migration, vimentin expression and eIF4E/CYFIP1 binding

Biochemical Journal

Volumn 467, Issue 1, 2015, Pages 63-76

  Beggs, James E ^a   Tian, Shuye ^a   Jones, Greg G ^a   Xie, Jianling ^a   Iadevaia, Valentina ^a   Jenei, Veronika ^b   Thomas, Gareth ^b   Proud, Christopher G ^a,c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

CYFIP1; eIF4E; EMT; Mnk; Translation

Indexed keywords

CYTOPLASMIC FMRP INTERACTING PROTEIN 1; FRAGILE X MENTAL RETARDATION PROTEIN; INITIATION FACTOR 4E; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INTERACTING KINASE; UNCLASSIFIED DRUG; VIMENTIN; CYFIP1 PROTEIN, MOUSE; MKNK1 PROTEIN, MOUSE; MKNK2 PROTEIN, MOUSE; MUTANT PROTEIN; NERVE PROTEIN; PROTEIN KINASE INHIBITOR; PROTEIN SERINE THREONINE KINASE; RECOMBINANT PROTEIN; TUMOR PROTEIN;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL CYCLE; CELL MIGRATION; CONTROLLED STUDY; ENZYME REGULATION; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MESENCHYME CELL; MOUSE; NONHUMAN; POLYSOME; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WOUND HEALING; ANIMAL; ANIMAL EMBRYO; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL MOTION; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; RNA INTERFERENCE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; EMBRYO, MAMMALIAN; EUKARYOTIC INITIATION FACTOR-4E; GENE EXPRESSION REGULATION; HUMANS; MICE; MUTANT PROTEINS; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT PROTEINS; RNA INTERFERENCE; VIMENTIN; WOUND HEALING;

EID: 84929941775     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20141066     Document Type: Article

References (54)

1. Waskiewicz, A.J., Flynn, A., Proud, C.G. and Cooper, J.A. (1997) Mitogen-activated kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16, 1909-1920 CrossRef PubMed
2. Fukunaga, R. and Hunter, T. (1997) Mnk1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 16, 1921-1933 CrossRef PubMed
3. Buxade, M., Parra-Palau, J.L. and Proud, C.G. (2008) The Mnks: MAP kinase-interacting kinases (MAP kinase signal-integrating kinases). Front. Biosci. 13, 5359-5373 CrossRef PubMed
4. Fischer, P.M. (2009) Cap in hand: targeting eIF4E. Cell Cycle. 8, 2535-2541 CrossRef PubMed
5. Ueda, T., Sasaki, M., Elia, A.J., Chio, I.I., Hamada, K., Fukunaga, R. and Mak, T.W. (2010) Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development. Proc. Natl. Acad. Sci. U.S.A. 107, 13984-13990 CrossRef PubMed
6. Furic, L., Rong, L., Larsson, O., Koumakpayi, I.H., Yoshida, K., Brueschke, A., Petroulakis, E., Robichaud, N., Pollak, M., Gaboury, L.A. et al. (2010) eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression. Proc. Natl. Acad. Sci. U.S.A. 107, 14134-14139 CrossRef PubMed
7. Flynn, A. and Proud, C.G. (1995) Serine 209, not serine 53, is the major site of phosphorylation in initiation factor eIF-4E in serum-treated Chinese hamster ovary cells. J. Biol. Chem. 270, 21684-21688 CrossRef PubMed
8. Joshi, B., Cai, A.L., Keiper, B.D., Minich, W.B., Mendez, R., Beach, C.M., Stolarski, R., Darzynkiewicz, E. and Rhoads, R.E. (1995) Phosphorylation of eukaryotic protein synthesis initiation factor 4E at serine 209. J. Biol. Chem. 270, 14597-14603 CrossRef PubMed
9. Scheper, G.C. and Proud, C.G. (2002) Does phosphorylation of the cap-binding protein eIF4E play a role in translation initiation? Eur. J. Biochem. 269, 5350-5359 CrossRef PubMed
10. Scheper, G.C., van Kollenburg, B., Hu, J., Luo, Y., Goss, D.J. and Proud, C.G. (2002) Phosphorylation of eukaryotic initiation factor 4E markedly reduces its affinity for capped mRNA. J. Biol. Chem. 277, 3303-3309 CrossRef PubMed
11. Zuberek, J., Jemielity, J., Jablonowska, A., Stepinski, J., Dadlez, M., Stolarski, R. and Darzynkiewicz, E. (2004) Influence of electric charge variation at residues 209 and 159 on the interaction of eIF4E with the mRNA 5′ terminus. Biochemistry 43, 5370-5379 CrossRef PubMed
12. Ueda, T., Watanabe-Fukunaga, R., Fukuyama, H., Nagata, S. and Fukunaga, R. (2004) Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol. Cell. Biol. 24, 6539-6549 CrossRef PubMed
13. Wang, X., Flynn, A., Waskiewicz, A.J., Webb, B.L.J., Vries, R.G., Baines, I.A., Cooper, J. and Proud, C.G. (1998) The phosphorylation of eukaryotic initiation factor eIF4E in response to phorbol esters, cell stresses and cytokines is mediated by distinct MAP kinase pathways. J. Biol. Chem. 273, 9373-9377 CrossRef PubMed
14. Scheper, G.C., Morrice, N.A., Kleijn, M. and Proud, C.G. (2001) The MAP kinase signal-integrating kinase Mnk2 is an eIF4E kinase with high basal activity in mammalian cells. Mol. Cell. Biol. 21, 743-754 CrossRef PubMed
15. Hou, J., Lam, F., Proud, C. and Wang, S. (2012) Targeting mnks for cancer therapy. Oncotarget 3, 118-131 PubMed
16. Robichaud, N., Del Rincon, S.V., Huor, B., Alain, T., Petruccelli, L.A., Hearnden, J., Goncalves, C., Grotegut, S., Spruck, C.H., Furic, L. et al. (2014) Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3. Oncogene, doi:10.1038/onc.2014.146
17. Grzmil, M., Morin, Jr, P., Lino, M.M., Merlo, A., Frank, S., Wang, Y., Moncayo, G. and Hemmings, B.A. (2011) MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-beta signaling pathway in human glioblastoma. Cancer Res. 71, 2392-2402 CrossRef PubMed
18. Napoli, I., Mercaldo, V., Boyl, P.P., Eleuteri, B., Zalfa, F., De, R.S., Di, M.D., Mohr, E., Massimi, M., Falconi, M. et al. (2008) The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Cell 134, 1042-1054 CrossRef PubMed
19. Ascano, Jr, M., Mukherjee, N., Bandaru, P., Miller, J.B., Nusbaum, J.D., Corcoran, D.L., Langlois, C., Munschauer, M., Dewell, S., Hafner, M. et al. (2012) FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature 492, 382-386 CrossRef PubMed
20. Darnell, J.C., Van Driesche, S.J., Zhang, C., Hung, K.Y., Mele, A., Fraser, C.E., Stone, E.F., Chen, C., Fak, J.J., Chi, S.W. et al. (2011) FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247-261 CrossRef PubMed
21. Luca, R., Averna, M., Zalfa, F., Vecchi, M., Bianchi, F., La, F.G., Del, N.F., Nardacci, R., Bianchi, M., Nuciforo, P. et al. (2013) The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation. EMBO Mol. Med. 5, 1523-1536 CrossRef PubMed
22. Tschopp, C., Knauf, U., Brauchle, M., Zurini, M., Ramage, P., Glueck, D., New, L., Han, J. and Gram, H. (2000) Phosphorylation of eIF-4E on Ser 209 in response to mitogenic and inflammatory stimuli is faithfully detected by specific antibodies. Mol. Cell Biol. Res. Commun. 3, 205-211 CrossRef PubMed
23. Liu, R., Iadevaia, V., Averous, J., Taylor, P.M., Zhang, Z. and Proud, C.G. (2014) Impairing the production of ribosomal RNA activates mammalian target of rapamycin complex 1 signalling and downstream translation factors. Nucleic Acids Res. 42, 5083-5096 CrossRef PubMed
24. Thomas, G.J., Poomsawat, S., Lewis, M.P., Hart, I.R., Speight, P.M. and Marshall, J.F. (2001) alpha v beta 6 Integrin upregulates matrix metalloproteinase 9 and promotes migration of normal oral keratinocytes. J. Invest. Dermatol. 116, 898-904 CrossRef PubMed
25. Barlow, A.D., Xie, J., Moore, C.E., Campbell, S.C., Shaw, J.A., Nicholson, M.L. and Herbert, T.P. (2012) Rapamycin toxicity in MIN6 cells and rat and human islets is mediated by the inhibition of mTOR complex 2 (mTORC2). Diabetologia 55, 1355-1365 CrossRef PubMed
26. Iadevaia, V., Wang, X., Yao, Z., Foster, L.J. and Proud, C.G. (2012) Evaluation of mTOR-regulated mRNA translation. Methods Mol. Biol. 821, 171-185 CrossRef PubMed
27. Stead, R.L. and Proud, C.G. (2013) Rapamycin enhances eIF4E phosphorylation by activating MAP kinase-interacting kinase 2a (Mnk2a). FEBS Lett 587, 2623-2628 CrossRef PubMed
28. Konicek, B.W., Stephens, J.R., McNulty, A.M., Robichaud, N., Peery, R.B., Dumstorf, C.A., Dowless, M.S., Iversen, P.W., Parsons, S., Ellis, K.E. et al. (2011) Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases. Cancer Res 71, 1849-1857 CrossRef PubMed
29. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C.J., McLauchlan, H., Klevernic, I., Arthur, J.S., Alessi, D.R. and Cohen, P. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297-315 CrossRef PubMed
30. Pende, M., Um, S.H., Mieulet, V., Sticker, M., Goss, V.L., Mestan, J., Mueller, M., Fumagalli, S., Kozma, S.C. and Thomas, G. (2004) S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol. Cell Biol. 24, 3112-3124 CrossRef PubMed
31. Sarbassov, D.D., Guertin, D.A., Ali, S.M. and Sabatini, D.M. (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101 CrossRef PubMed
32. Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Ruegg, M.A., Hall, A. and Hall, M.N. (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122-1128 CrossRef PubMed
33. Grzmil, M., Huber, R.M., Hess, D., Frank, S., Hynx, D., Moncayo, G., Klein, D., Merlo, A. and Hemmings, B.A. (2014) MNK1 pathway activity maintains protein synthesis in rapalog-treated gliomas. J. Clin. Invest. 124, 742-754 CrossRef PubMed
34. To, K., Fotovati, A., Reipas, K.M., Law, J.H., Hu, K., Wang, J., Astanehe, A., Davies, A.H., Lee, L., Stratford, A.L. et al. (2010) Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance. Cancer Res 70, 2840-2851 CrossRef PubMed
35. Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674 CrossRef PubMed
36. Yan, C., Grimm, W.A., Garner, W.L., Qin, L., Travis, T., Tan, N. and Han, Y.P. (2010) Epithelial to mesenchymal transition in human skin wound healing is induced by tumor necrosis factor-alpha through bone morphogenic protein-2. Am. J. Pathol. 176, 2247-2258 CrossRef PubMed
37. Thiery, J.P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442-454 CrossRef PubMed
38. Yang, J., Mani, S.A., Donaher, J.L., Ramaswamy, S., Itzykson, R.A., Come, C., Savagner, P., Gitelman, I., Richardson, A. and Weinberg, R.A. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939 CrossRef PubMed
39. Wang, Y., Shi, J., Chai, K., Ying, X. and Zhou, B.P. (2013) The role of snail in EMT and tumorigenesis. Curr. Cancer Drug Targets. 13, 963-972 CrossRef PubMed
40. Thiery, J.P. and Sleeman, J.P. (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7, 131-142 CrossRef PubMed
41. Vandewalle, C., Comijn, J., De, C.B., Vermassen, P., Bruyneel, E., Andersen, H., Tulchinsky, E., Van, R.F. and Berx, G. (2005) SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res 33, 6566-6578 CrossRef PubMed
42. Bindels, S., Mestdagt, M., Vandewalle, C., Jacobs, N., Volders, L., Noel, A., Van, R.F., Berx, G., Foidart, J.M. and Gilles, C. (2006) Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene 25, 4975-4985 CrossRef PubMed
43. Schenck, A., Bardoni, B., Moro, A., Bagni, C. and Mandel, J.L. (2001) A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P. Proc. Natl. Acad. Sci. U.S.A. 98, 8844-8849 CrossRef PubMed
44. Pollitt, A.Y. and Insall, R.H. (2009) WASP and SCAR/WAVE proteins: the drivers of actin assembly. J. Cell Sci. 122, 2575-2578 CrossRef PubMed
45. Santarpia, L., Lippman, S.M. and El-Naggar, A.K. (2012) Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert. Opin. Ther. Targets. 16, 103-119 CrossRef PubMed
46. Corbin, F., Bouillon, M., Fortin, A., Morin, S., Rousseau, F. and Khandjian, E.W. (1997) The fragile X mental retardation protein is associated with poly(A) + mRNA in actively translating polyribosomes. Hum. Mol. Genet. 6, 1465-1472 CrossRef PubMed
47. Feng, Y., Absher, D., Eberhart, D.E., Brown, V., Malter, H.E. and Warren, S.T. (1997) FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol. Cell 1, 109-118 CrossRef PubMed
48. Chen, E., Sharma, M.R., Shi, X., Agrawal, R.K. and Joseph, S. (2014) Fragile X mental retardation protein regulates translation by binding directly to the ribosome. Mol. Cell 54, 407-417 CrossRef PubMed
49. Willett, M., Brocard, M., Davide, A. and Morley, S.J. (2011) Translation initiation factors and active sites of protein synthesis co-localize at the leading edge of migrating fibroblasts. Biochem. J. 438, 217-227 CrossRef PubMed
50. Willett, M., Brocard, M., Pollard, H.J. and Morley, S.J. (2013) mRNA encoding WAVE-Arp2/3-associated proteins is co-localized with foci of active protein synthesis at the leading edge of MRC5 fibroblasts during cell migration. Biochem. J. 452, 45-55 PubMed
51. Willett, M., Pollard, H.J., Vlasak, M. and Morley, S.J. (2010) Localization of ribosomes and translation initiation factors to talin/beta3-integrin-enriched adhesion complexes in spreading and migrating mammalian cells. Biol. Cell 102, 265-276 CrossRef PubMed
52. Panja, D., Kenney, J.W., D'Andrea, L., Zalfa, F., Vedeler, A., Wibrand, K., Fukunaga, R., Bagni, C., Proud, C.G. and Bramham, C.R. (2014) Two-stage translational control of dentate gyrus LTP consolidation is mediated by sustained BDNF-TrkB signaling to MNK. Cell Rep 9, 1430-1445 CrossRef PubMed
53. Ramalingam, S., Gediya, L., Kwegyir-Afful, A.K., Ramamurthy, V.P., Purushottamachar, P., Mbatia, H. and Njar, V.C. (2014) First MNKs degrading agents block phosphorylation of eIF4E, induce apoptosis, inhibit cell growth, migration and invasion in triple negative and Her2-overexpressing breast cancer cell lines. Oncotarget 5, 530-543 PubMed
54. Joshi, S., Sharma, B., Kaur, S., Majchrzak, B., Ueda, T., Fukunaga, R., Verma, A.K., Fish, E.N. and Platanias, L.C. (2011) Essential role for Mnk kinases in type II interferon (IFNgamma) signaling and its suppressive effects on normal hematopoiesis. J. Biol. Chem. 286, 6017-6026 CrossRef PubMed